Clinical study of onychomycosis: Factors contributing to the prognosis and response rate according to each factor and summation of factors

Korean Journal of Medical Mycology

Volumn 10, Issue 2, 2005, Pages 55-69

  Kim, Duk Han ^a   Park, Hyun Jeong ^a   Lee, Jun Young ^a   Cho, Baik Kee ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Good responder; Odds ratio; Onychomycosis; Prognosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; FEMALE; FUNGUS CULTURE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NAIL DISEASE; ONYCHOLYSIS; ONYCHOMYCOSIS; PROGNOSIS; SMEAR; TREATMENT OUTCOME; TREATMENT PLANNING;

FUNGI;

EID: 26044444519     PISSN: 12264709     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Scher RK. Onychomycosis: A significant medical disorder. J Am Acad Dermatol 1996; 35: S2-S5
2. Scher RK, Baran R. Onychomycosis in clinical practice: Factors contributing to recurrence. Br J Dermatol 2003; 149: S5-S9
3. Gupta AK, Jain HC, Lynde CW, et al. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: A multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol 2000;43:244-248
4. Gupta AK, Lynde CW, Jain HC, et al. A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre study. Br J Dermatol 1997; 136:786-789.
5. Roberts DT. Prevalence of dermatophyte onychomycosis in the United Kingdom: Results of an omnibus survey. Br J Dermatol 1992; 126: S23-S27
6. Heikkila H, Stubb S. The prevalence of onychomycosis in Finland. Br J Dermatol 1995; 133: 699-703
7. Sais G, Jucgla A, Peyri J. Prevalence of dermatophyte onychomycosis in Spain: A cross-sectional study. Br J Dermatol 1995; 132: 758-761
8. Gupta AK, Konnikov N, MacDonald P, et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: A multicentre survey. Br J Dermatol 1998; 139:665-671
9. Baran R, Hay RJ, Tosti A, Haneke E. A new classification of onychomycosis. Br J Dermatol 1998; 139: 567-571
10. st century. J Am Acad Dermatol 2000; 43: S96-102
11. English MP. Nail and fungi. Br J Dermatol 1976; 94: 697-701
12. Ellis DH. Diagnosis of onychomycosis may be simple. J Am Acad Dermatol 1999; 40: S3-S8
13. Arrese JE, Pierard-Franchimont C, Pierard GE. Facing up to the diagnostic uncertainty and management of onychomycoses. Int J Dermatol 1999; 38: S1-S6
14. Suarez SM, Silvers DN, Scher RK, et al. Histologic evaluation of nail clippings for diagnosing onychomycosis. Arch Dermatol 1991; 127: 1517-1519
15. Liu HN, Lee DD, Wong CK. KONCPA: A new method for diagnosing tinea unguium. Dermatology 1993; 187: 166-168
16. Bradley MC, Leidich S, Isham N, Elewski BE, Ghannoum MA. Antifungal susceptibibities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail. Mycoses 1999; 42: S105-S110
17. Gupta AK, Kohli Y. Evaluation of in vitro resistance in patients with onychomycosis who fail antifungal therapy. Dermatology 2003; 207: 375-380
18. Arrese JE, Pierard GE. Treatment failures and relapses in onychomycosis: A stubborn clinical problem. Dermatology 2003; 207: 255-260
19. Arrese JE, Pierard-Franchimont C, Pierard GE. A plea to bridge the gap between antifungals and the management of onychomycosis. Am J Clin Dermatol 2001; 2: 281-284
20. Pierard GE, Pierard-Franchimont C, Arrese JE. The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen. Dermatology 2000; 200: 185-187
21. Pierard GE, Pierard-Franchimont C, Arrese JE. The boosted antifungal topical treatment (BATT) for onychomycosis. Med Mycol 2000; 38: 391-392
22. Pierard G. Onychomycosis and other superficial fungal infections of the foot in the elderly: a pan-European survey. Dermatology 2001; 202: 220-224
23. Dompmartin D, Dompmartin A, Deluol AM, Grosshans E, Coulaud JP. Onychomycosis and AIDS. Clinical and laboratory findings in 62 patients. Int J Dermatol 1990; 29: 337-339
24. Roberts DT, Evans EGV. Subungual dermatophytoma complicating dermatophyte onychomycosis. Br J Dermatol 1998; 138: 189-190
25. Burkhart CN, Burkhart CG, Gupta AK. Dermatophytoma: Recalcitrance to treatment because of existence of fungal biofilm. J Am Acad Dermatol 2002; 47: 629-631
26. Baran R, de Doncker P. Lateral edge involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungals. Acta Derm Venereol 1996; 76: 82-83
27. Gupta AK, Daniel CR. Onychomycosis: Strategies to reduce failure and recurrence. Cutis 1998; 62: 189-191
28. Gupta AK, Konnikov N, Lynde CW. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. J Am Acad Dermatol 2001; 44: 479-484
29. Gupta AK, Baran R, Summerbell R. Onychomycosis: Strategies to improve efficacy and reduce recurrence. J Eur Acad Derm Venereol 2002; 16: 579-586
30. Sergeev AY, Gupta AK, Sergeev YV. The scoring clinical index for onychomycosis (SCIO index). Skin Therapy Lett 2002; 7: S6-S7